Sino Biopharmaceutical: Invitae supplementary application officially accepted by the National Medical Products Administration

Sini Pharmaceutical announced that the supplement application for the domestic production drug Envida has been officially accepted by the State Food and Drug Administration, changing from conditional approval to regular approval. The acceptance number is CYSB2600056, and the applied specification is 200mg/bottle. This application was submitted by Sichuan Silu Kangrui Pharmaceutical Co., Ltd., a subsidiary of the company, and the application materials were received and accepted after review on February 2, 2026.